| CRBU Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CRBU shares outstanding history going back to 7/23/2021:
Also see: CRBU Market Cap History CRBU YTD Return |
As of 4/30/2026 Caribou Biosciences has 99.18 million CRBU shares outstanding. Investors often track the CRBU shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CRBU share count trends over time, with 20 historical shares outstanding datapoints presented, dating back to 7/23/2021.

| CRBU Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CRBU shares outstanding history going back to 7/23/2021:
Also see: CRBU Market Cap History CRBU YTD Return |
| CRBU Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||
CRBU Historical Shares Outstanding: +14.86% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||
| CRBU Stock Price Chart |
| About Caribou Biosciences Inc |
| Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It is engaged in developing transformative therapies for patients with devastating diseases. Its genome-editing platform, including its Cas12a chRDNA technology, enables precision to develop cell therapies that are armored to potentially improve antitumor activity. Its pipeline includes three clinical-stage allogeneic cell therapies from its chimeric antigen receptor (CAR)-T (CAR-T) cell platform targeting the treatment of hematologic malignancies. We show 20 historical shares outstanding datapoints in our coverage of CRBU's shares outstanding history. Understanding the changing numbers of CRBU shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CRBU versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CRBU by allowing them to research CRBU shares outstanding history as well as any other stock in our coverage universe. |
| CRBU Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| CRBU Share Performance |
| Shares Outstanding Peers |
| Caribou Biosciences (CRBU) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CRDF Shares Outstanding History CRGX Shares Outstanding History CRH Shares Outstanding History CRIS Shares Outstanding History CRL Shares Outstanding History CRMD Shares Outstanding History CRNX Shares Outstanding History CRTX Shares Outstanding History CRVL Shares Outstanding History CRVO Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.